Inhibition of fMLP-triggered respiratory burst of human monocytes by adenosine: Involvement of A3 adenosine receptor

Journal of Leukocyte Biology

Volumn 66, Issue 3, 1999, Pages 495-501

  Broussas, Matthieu ^a   Cornillet Lefèbvre, Pascale ^a   Potron, Gérard ^a   Nguyen, Philippe ^b,c  

^a Lab d'Immunol et d'Hematologie   (France)

^b REIMS UNIVERSITY HOSPITAL   (France)

^c SERVICE DE DERMATOLOGIE   (France)

Author keywords

Chemiluminescence; NADPH oxidase; Transduction pathway

Indexed keywords

6 N (3 IODOBENZYL)ADENOSINE 5' N METHYLCARBOXAMIDE; 8 (2 AMINO 4 CHLOROPHENYL) 1,3 DIPROPYLXANTHINE; 8 [4 (2 AMINOETHYLCARBAMOYL)METHOXYPHENYL] 1,3 DIPROPYLXANTHINE; ADENOSINE; ADENOSINE A3 RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE RECEPTOR STIMULATING AGENT; BUCLADESINE; CALCIUM; CYTOCHALASIN B; DIPYRIDAMOLE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; KT 5720; MESSENGER RNA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; XANTHINE DERIVATIVE;

AEROBIC METABOLISM; ARTICLE; CALCIUM MOBILIZATION; CHEMOLUMINESCENCE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; RESPIRATORY BURST;

EID: 0032823080     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.66.3.495     Document Type: Article

References (39)

1. Olah, M. E., Stiles, G. L. (1995) Adenosine receptor subtypes: characterization and therapeutic regulation. Annu. Rev. Pharmacol. Toxicol. 35, 581-606.
2. Jonzon, B., Fredholm, B. B. (1984) Adenosine receptor mediated inhibition of noradrenaline release from slices of the rat hippocampus. Life Sci. 35, 1971-1979.
3. Ribeiro, J. A., Sebastião, A. M. (1987) On the role, inactivation and origin of endogenous adenosine at frog neuromuscular junction. J. Physiol. 384, 571-585.
4. Cronstein, B. N., Kramer, S. B., Weissmann, G., Hirschhorn, R. (1983) Adenosine: a physiological modulator of superoxide anion generation by human neutrophils. J. Exp. Med. 158, 1160-1177.
5. - generation, respectively. J. Clin. Invest. 85, 1150-1157.
6. Burkey, T. H., Webster, R. O. (1993) Adenosine inhibits fMLP-stimulated adherence and superoxide anion generation by neutrophils at early step in signal transduction. Biochim. Biophys. Acta 1175, 312-318.
7. Cronstein, B. N., Levin, R. I., Philips, M., Hirschhorn, R., Abramson, S. A., Weissmann, G. (1992) Neutrophil adherence to endothelium is enhanced via adenosine A1 receptors and inhibited via adenosine A2 receptors. J. Immunol. 148, 2201-2206.
8. Bullough, D. A., Magill, M. J., Firestein, G. S., Mullane, K. M. (1995) Adenosine activates A2 receptors to inhibit neutrophil adhesion and injury to cardiac myocytes. J. Immunol, 155, 2579-2586.
9. Wollner, A., Wollner S., Smith, J. B. (1993) Acting via A2 receptors, adenosine inhibits the upregulation of Mac-1 (CD11b/CD18) expression on FMLP-stimulated neutrophils. Am. J. Respir. Cell Mol. Biol. 9, 179-185.
10. Bouma, M. G., Jeuhomme, T. M. M. A., Boyle, D. L., Dentener, M. A., Voitenok, N. N., van den Wildenberg, F. A. J. M., Buurman, W. A. (1997) Adenosine inhibits neutrophil degranulation in activated human whole blood. J. Immunol. 158, 5400-5408.
11. Jordan, J. E., Thourani, V. H., Long Hosp, C., Auchampach, J. A. (1998) A3 adenosine receptor activation reduced PMN-endothelial cell interaction without effect on free radicals and degranulation. Circ. 98 (Suppl. 1), 666 (Abstract).
12. Rose, F. R., Hirschhorn, R., Weissmann, G., Cronstein, B. N. (1988) Adenosine promotes neutrophil chemotaxis. J. Exp. Med. 167, 1186-1194.
13. Leonard, E. J., Shenai, A., Skeel, A. (1987) Dynamics of chemotactic peptide-induced superoxide generation by human monocytes. Inflammation 11, 229-240.
14. Lappin, D., Whaley, K. (1984) Adenosine A2 receptors on human monocytes modulate C2 production. Clin. Exp. Immunol. 57, 454-460.
15. Si, Q. S., Nakamura, Y., Kataoka, K. (1997) Adenosine inhibits superoxide production in rat peritoneal macrophages via elevation of cAMP level. Immunopharmacol. 36, 1-7.
16. Bouma, M. G., Stad, R. K., van den Wildenberg, F. A. J. M., Buurman, W. A. (1994) Differential regulatory effects of adenosine on cytokine release by activated human monocytes. J. Immunol. 153, 4159-4168.
17. Le Moine, O., Stordeur, P., Shandené, L., Marchant, A., de Groote, D., Goldman, M., Devière, J. (1996) Adenosine enhances IL-10 secretion by human monocytes. J. Immunol. 156, 4408-4414.
18. Bowlin, T. L., Borcherding, D. R., Edwards, C. K., McWhinney, C. D. (1997) Adenosine A3 receptor agonists inhibit murine macrophage tumor necrosis factor-alpha production in vitro and in vivo. Cell. Mol. Biol. 43, 345-349.
19. Szabo, C., Scott, G. S., Virag, L., Egnaczyk, G., Salzman, A. L., Shanley, T. P., Hasko, G. (1998) Suppression of macrophages inflammatory protein (MIP)-1 alpha production and collagen-induced arthritis by adenosine receptor agonists. Br. J. Pharmacol. 125, 379-387.
20. Haskó, G., Szabó, C., Németh, Z. H., Kvetan, V., Mc Carthy Pastores, S., Vizi, E. S. (1996) Adenosine receptor agonists differentially regulate IL-10, TNF-α, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice. J. Immunol. 157, 4634-4640.
21. Lopez, M., Fechtenhaum, J., David, B., Martinache, C., Chokri, M., Canepa, S., De Gramont, A., Louvt, C., Gorin, I., Mortel, O., Bartholeyns, J. (1992) Adoptive immunotherapy with activated macrophages grown in vitro from blood monocytes in cancer patients: a pilot study. J. Immunother. 11, 209-217.
22. Hasegawa, H., Suzuki, K., Nakaji, S., Sugawara, K. (1997) Analysis and assessment of the capacity of neutrophils to produce reactive oxygen species in a 96-well microplate format using licigenin- and luminol-dependent chemiluminescence. J. Immunol. Meth. 210, 1-10.
23. Rabesandratana, H., Fournier, A. M., Château, M. T., Serre, A., Dornand, J. (1992) Increased oxidative metabolism in PMA-activated lymphocytes: a flow cytometric study. Int. J. Immunopharmacol. 14, 895-902.
24. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260, 3440-3450.
25. Grigoriadis, G., Stewart, A. G. (1991) 1-O-hexadecyl-2-acetyl-sn-glycero-3-phospho (N,N,N trimethyl) hexanolamine: an analogue of platelet-activating factor with partial agonist activity. Br. J. Pharmacol. 104, 171-177.
26. Sajjadi, F. G., Takabayashi, K., Foster, A. C., Domingo, R. C., Firestein, G. S. (1996) Inhibition of TNF-α expression by adenosine: a role of A3 adenosine receptor. J. Immunol. 156, 3435-3442.
27. Jacobson, K. A., van Galen, J. M., Williams, M. (1992) Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential. J. Med. Chem. 35, 407-422.
28. Lad, P. M., Goldberg, B. J., Smiley P. A., Olson, C. V. (1985) Receptor-specific threshold effects of cyclic AMP are involved in the regulation of enzyme release and superoxide production from human neutrophils. Biochim. Biophys. Acta 846, 286-295.
29. Kase, H., Iwahashi, K., Nakanishi, S., Matsuda, Y., Yamada, K., Takahashi, M., Murakata, C., Sato, A., Kaneko, M. (1987) K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleolide-dependent protein kinases. Biochem. Biophys. Res. Commun. 142, 436-440.
30. Zhou, Q. Y., Li, C., Olah, M. E., Johnson, R. A., Stiles, G. L., Givelli, O. (1992) Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor. Proc. Natl. Acad. Sci. USA 89, 7432-7436.
31. Salvatore, C. A., Jacobson, M. A., Taylor, H. E., Linden, J., Johnson, R. G. (1993) Molecular cloning and characterization of the human A3 adenosine receptor. Proc. Natl. Acad. Sci. USA 90, 10365-10369.
32. Eppel, B., Newell, A. M., Brown, E. J. (1989) Adenosine receptors are expressed during differentiation of monocytes to macrophages in vitro. J. Immunol. 143, 4141-4145.
33. Salmon, J. E., Brogle, N., Brownlie, C., Edberg, J. C., Kimberly, R. P., Chen, B. X., Erlanger, B. F. (1993) Human mononuclear phagocytes express adenosine A1 receptors. J. Immunol. 151, 2775-2785.
34. Mueller, H., Sklar, L. A. (1989) Coupling of antagonistic signaling pathways in modulation of neutrophil function. J. Cell Biochem. 40, 287-294.
35. Della Bianca, V., De Togni, P., Grzeskowiak, M., Vincentini, L. M., Di Virgilio, F. (1986) Cyclic AMP inhibition of phosphoinositides turnover in human neutrophils. Biochem. Biophys. Acta 86, 441-487.
36. Kato, H., Ishitoya, J., Takenawa, T. (1986) Inhibition of inositol phospholipids metabolism and calcium mobilization by cyclic AMP-increasing agents and phorbol ester in neutrophils. Biochem. Biophys. Res. Commun. 139, 1272-1278.
37. Fällman, M., Lew, D. P., Stendahl, O., Andersson, T. (1989) Receptor-mediated phagocytosis in human neutrophils is associated with increased formation of inositolphosphates and diacylglycerol. Elevation in cytosolic free calcium and formation of inositolphosphates can be dissociated from accumulation of diacyglycerol. J. Clin. Invest. 84, 886-891.
38. Takenawa, T., Ishitoya, J., Nagai, Y. (1986) Inhibitory effect of prostaglandin E2, forskolin, and dibutyryl cAMP on arachidonic acid release and inositol phospholipid metabolism in guinea pig neutrophils. J. Biol. Chem. 261, 1092-1098.
39. Ramkumar, V., Stiles, G. L., Beaven, M. A., Ali, H. (1993) The A3AR is the unique adenosine receptor which facilitates release of allergic mediators in mast cells. J. Biol. Chem. 268, 16871-16890.